155 related articles for article (PubMed ID: 17910279)
1. Relationship between level of circulating modified LDL and the extent of coronary artery disease in type 2 diabetic patients.
El-Bassiouni EA; Helmy MH; El-Zoghby SM; El-Nabi Kamel MA; Hosny RM
Br J Biomed Sci; 2007; 64(3):109-16. PubMed ID: 17910279
[TBL] [Abstract][Full Text] [Related]
2. Elevated beta2-glycoprotein I-low-density lipoprotein levels are associated with the presence of diabetic microvascular complications.
Yu R; Yuan Y; Niu D; Song J; Liu T; Wu J; Wang J
J Diabetes Complications; 2015; 29(1):59-63. PubMed ID: 25449980
[TBL] [Abstract][Full Text] [Related]
3. Regulation of low-density lipoprotein particle size distribution in NIDDM and coronary disease: importance of serum triglycerides.
Lahdenperä S; Syvänne M; Kahri J; Taskinen MR
Diabetologia; 1996 Apr; 39(4):453-61. PubMed ID: 8777995
[TBL] [Abstract][Full Text] [Related]
4. Soluble LDL-immune complexes in type 2 diabetes and vascular disease.
Turk Z; Sesto M; Skodlar J; Ferencak G; Turk N; Stavljenić-Rukavina A
Horm Metab Res; 2002 Apr; 34(4):196-201. PubMed ID: 11987029
[TBL] [Abstract][Full Text] [Related]
5. Correlation of plasma oxidized low-density lipoprotein levels to vascular complications and human serum paraoxonase in patients with type 2 diabetes.
Tsuzura S; Ikeda Y; Suehiro T; Ota K; Osaki F; Arii K; Kumon Y; Hashimoto K
Metabolism; 2004 Mar; 53(3):297-302. PubMed ID: 15015140
[TBL] [Abstract][Full Text] [Related]
6. [Oxidized LDL and lipids as risk factors for ischemic heart disease in type 2 diabetes].
Zamaklar M; Lalić K; Rajković N; Trifunović D; Dragasević M; Popović L; Drasković D; Laić N; Jotić A; Vasović O; Lukić L; Milicić T; Potpara T
Vojnosanit Pregl; 2005; 62(7-8):529-36. PubMed ID: 16171015
[TBL] [Abstract][Full Text] [Related]
7. Investigation of MDA-LDL (malondialdehyde-modified low-density lipoprotein) as a prognostic marker for coronary artery disease in patients with type 2 diabetes mellitus.
Kotani K; Tashiro J; Yamazaki K; Nakamura Y; Miyazaki A; Bujo H; Saito Y; Kanno T; Maekawa M
Clin Chim Acta; 2015 Oct; 450():145-50. PubMed ID: 26265234
[TBL] [Abstract][Full Text] [Related]
8. Plasma oxidized low-density lipoprotein is an independent risk factor in young patients with coronary artery disease.
Huang Y; Hu Y; Mai W; Cai X; Song Y; Wu Y; Dong Y; Huang H; He Z; Li W; Yang Y; Rao S
Dis Markers; 2011; 31(5):295-301. PubMed ID: 22048271
[TBL] [Abstract][Full Text] [Related]
9. Serum high-density lipoprotein-cholesterol levels modify the association between plasma levels of oxidatively modified low-density lipoprotein and coronary artery disease in men.
Zhang B; Bai H; Liu R; Kumagai K; Itabe H; Takano T; Saku K
Metabolism; 2004 Apr; 53(4):423-9. PubMed ID: 15045686
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of Serum Levels of Inflammation, Fibrinolysis and Oxidative Stress Markers in Coronary Artery Disease Prediction: A Cross-Sectional Study.
Abolhasani S; Shahbazloo SV; Saadati HM; Mahmoodi N; Khanbabaei N
Arq Bras Cardiol; 2019; 113(4):667-674. PubMed ID: 31482948
[TBL] [Abstract][Full Text] [Related]
11. Plasma levels of oxidized-low-density lipoproteins are higher in patients with unstable angina and correlated with angiographic coronary complex plaques.
Anselmi M; Garbin U; Agostoni P; Fusaro M; Pasini AF; Nava C; Keta D; Turri M; Zardini P; Vassanelli C; Lo Cascio V; Cominacini L
Atherosclerosis; 2006 Mar; 185(1):114-20. PubMed ID: 15998517
[TBL] [Abstract][Full Text] [Related]
12. Relationships between low-density lipoprotein particle size, plasma lipoproteins, and progression of coronary artery disease: the Diabetes Atherosclerosis Intervention Study (DAIS).
Vakkilainen J; Steiner G; Ansquer JC; Aubin F; Rattier S; Foucher C; Hamsten A; Taskinen MR;
Circulation; 2003 Apr; 107(13):1733-7. PubMed ID: 12665498
[TBL] [Abstract][Full Text] [Related]
13. Oxidized-LDL is a useful marker for predicting the very early coronary artery disease and cardiovascular outcomes.
Zhao X; Zhang HW; Xu RX; Guo YL; Zhu CG; Wu NQ; Gao Y; Li JJ
Per Med; 2018 Nov; 15(6):521-529. PubMed ID: 30362886
[TBL] [Abstract][Full Text] [Related]
14. Pathophysiological role of oxidized low-density lipoprotein in plaque instability in coronary artery diseases.
Ehara S; Ueda M; Naruko T; Haze K; Matsuo T; Ogami M; Ikura Y; Itabe H; Komatsu R; Yoshiyama M; Takeuchi K; Yoshikawa J
J Diabetes Complications; 2002; 16(1):60-4. PubMed ID: 11872369
[TBL] [Abstract][Full Text] [Related]
15. Atherogenic lipoproteins and diabetes mellitus.
Yoshino G; Hirano T; Kazumi T
J Diabetes Complications; 2002; 16(1):29-34. PubMed ID: 11872363
[TBL] [Abstract][Full Text] [Related]
16. Oxidized low-density lipoprotein is negatively correlated with lecithin-cholesterol acyltransferase activity in type 2 diabetes mellitus.
Nakhjavani M; Asgharani F; Khalilzadeh O; Esteghamati A; Ghaneei A; Morteza A; Anvari M
Am J Med Sci; 2011 Feb; 341(2):92-5. PubMed ID: 20890173
[TBL] [Abstract][Full Text] [Related]
17. Protective effects of paraoxonase-1, vitamin E and selenium, and oxidative stress index on the susceptibility of low density lipoprotein to oxidation in diabetic patients with/without coronary artery disease.
Mehvari F; Imanparast F; Mohaghegh P; Alimoradian A; Khansari N; Ansari Asl B; Khosrowbeygi A
Eur J Med Res; 2023 Aug; 28(1):300. PubMed ID: 37635255
[TBL] [Abstract][Full Text] [Related]
18. Relation of oxidized-low-density lipoprotein and high-density lipoprotein subfractions in non-treated patients with coronary artery disease.
Zhao X; Zhang HW; Sun D; Xu RX; Guo YL; Sun J; Zhu CG; Wu NQ; Zhang Y; Li S; Li JJ
Prostaglandins Other Lipid Mediat; 2019 Oct; 144():106345. PubMed ID: 31278984
[TBL] [Abstract][Full Text] [Related]
19. Lipid profile in patients with coronary artery disease.
Haddad FH; Omari AA; Shamailah QM; Malkawi OM; Shehab AI; Mudabber HK; Shubaki MK
Saudi Med J; 2002 Sep; 23(9):1054-8. PubMed ID: 12370711
[TBL] [Abstract][Full Text] [Related]
20. Small low-density lipoprotein and small low-density lipoprotein/total low-density lipoprotein are closely associated with intima-media thickness of the carotid artery in Type 2 diabetic patients.
Inukai T; Yamamoto R; Suetsugu M; Matsumoto S; Wakabayashi S; Inukai Y; Matsutomo R; Takebayashi K; Aso Y
J Diabetes Complications; 2005; 19(5):269-75. PubMed ID: 16112502
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
